Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedGuide burden is increasing, FDA acknowledges

Executive Summary

FDA has increased its estimate on the amount of time that it takes a pharmacist to dispense a Medication Guide, boosting the time from 5 seconds to 3 minutes - a 3,600 percent increase - in response to pharmacy industry comments. FDA is also increasing its estimate for the number of guides FDA receives per year to 25 from 10. Pharmacy groups have been pressing FDA to overhaul how MedGuides are distributed, and the proliferation in MedGuides stemming from Risk Evaluation and Mitigation Strategies will likely make their demands grow louder (1"The Pink Sheet," Aug. 25, 2008, p. 9). The agency also said it agrees with a comment that there are distributor costs to complying with MedGuide requirements and its burden to distributors and packers should be included in the overall analysis. However, the agency is asking for more specific estimates before making a precise burden estimate. Increased burden estimates could help entities in the distribution chain seek more reimbursement for handling MedGuides

You may also be interested in...



MedGuide Requirements Need To Be Overhauled, Pharmacy Groups Tell FDA

FDA's use of Medication Guides is being challenged by pharmacy groups just as the documents are taking on growing importance as a cornerstone of the agency's new safety powers

Vaccine Experts Inject Realism Into US Gov't's COVID-19 Timeline

The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval. 

Trump Pushes Back On OIG Report That Hospitals Want Feds To Better Police Resources, Relax Regs

When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.

UsernamePublicRestriction

Register

PS050391

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel